BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,679,540 | -17.2% | 71,000 | 0.0% | 0.39% | -13.0% |
| Q2 2023 | $3,234,760 | +12.3% | 71,000 | 0.0% | 0.45% | +6.3% |
| Q1 2023 | $2,879,760 | -20.4% | 71,000 | 0.0% | 0.43% | -24.5% |
| Q4 2022 | $3,618,870 | +60.0% | 71,000 | +69.0% | 0.56% | +51.2% |
| Q3 2022 | $2,262,000 | +67.7% | 42,000 | +100.0% | 0.37% | +102.7% |
| Q2 2022 | $1,349,000 | +247.7% | 21,000 | +320.0% | 0.18% | +308.9% |
| Q1 2022 | $388,000 | -74.6% | 5,000 | -87.5% | 0.04% | -78.9% |
| Q4 2015 | $1,526,000 | +16.1% | 40,000 | 0.0% | 0.21% | +60.2% |
| Q3 2015 | $1,314,000 | -53.0% | 40,000 | 0.0% | 0.13% | -53.0% |
| Q2 2015 | $2,797,000 | +2.1% | 40,000 | 0.0% | 0.28% | 0.0% |
| Q1 2015 | $2,740,000 | -6.5% | 40,000 | 0.0% | 0.28% | -12.7% |
| Q4 2014 | $2,932,000 | +16.7% | 40,000 | +14.3% | 0.32% | -6.1% |
| Q3 2014 | $2,512,000 | -56.6% | 35,000 | -56.2% | 0.34% | -49.3% |
| Q2 2014 | $5,784,000 | -1.7% | 80,000 | 0.0% | 0.68% | +8.6% |
| Q1 2014 | $5,886,000 | +5.8% | 80,000 | 0.0% | 0.63% | +5.9% |
| Q4 2013 | $5,564,000 | +12.9% | 80,000 | +6.7% | 0.59% | +10.2% |
| Q3 2013 | $4,927,000 | -5.2% | 75,000 | 0.0% | 0.54% | +5.1% |
| Q2 2013 | $5,195,000 | – | 75,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |